Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Don't expect a sell-off
IMO the negative ITC decision was priced in the current shareprice. As Ron said, we have a clear victory regarding infringement, hence Otteson should concentrate on this venue. Maybe today's decision will help getting rid of Leckrone in the BK case?
Share
New Message
Please login to post a reply